IP Library Assignment 048418/0779
Patent Assignment
Reel/Frame 048418/0779

Assignment of Assignor's Interest

Recorded: 2019-02-24 Pages: 2
Assignor
WEIDANZ, JON
Executed: 2019-02-22
Assignee
ABEXXA BIOLOGICS, INC.
NANOFAB BUILDING, BOX 19072, ARLINGTON, TEXAS, 76019
Covered Property (1)
Combination Cancer Therapy with Anti-Cancer Agents and Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen
Application: 62/634,522 →
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Jan 6, 2022
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 058584/0680 →
Assignment of Assignor's Interest Nov 1, 2022
From: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 061615/0332 →